FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR
PR Newswire —
FAST III was initiated five years ago to evaluate whether revascularization guided by angiography–based FFR using CAAS vFFR (vessel Fractional Flow Reserve) delivers therapeutic outcomes comparable to those achieved with pressure wire–based FFR. Positive non-inferior result validates...